BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Figueiredo FA, Giovannini M, Monges G, Bories E, Pesenti C, Caillol F, Delpero JR. EUS-FNA predicts 5-year survival in pancreatic endocrine tumors. Gastrointest Endosc. 2009;70:907-914. [PMID: 19640525 DOI: 10.1016/j.gie.2009.05.020] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gallotti A, Johnston RP, Bonaffini PA, Ingkakul T, Deshpande V, Fernández-del Castillo C, Sahani DV. Incidental neuroendocrine tumors of the pancreas: MDCT findings and features of malignancy. AJR Am J Roentgenol. 2013;200:355-362. [PMID: 23345357 DOI: 10.2214/ajr.11.8037] [Cited by in Crossref: 49] [Cited by in F6Publishing: 13] [Article Influence: 6.1] [Reference Citation Analysis]
2 Chen L, Nassar A, Kommineni VT, Zarka MA, Zhang J, Faigel D, Nguyen C, Halfdanarson TR, Pannala R. Endoscopic ultrasonography-guided fine-needle aspiration cytology of surgically confirmed cystic pancreatic neuroendocrine tumors: a Mayo Clinic experience. J Am Soc Cytopathol 2015;4:335-43. [PMID: 31051748 DOI: 10.1016/j.jasc.2015.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
3 Sahani DV, Bonaffini PA, Fernández-Del Castillo C, Blake MA. Gastroenteropancreatic neuroendocrine tumors: role of imaging in diagnosis and management. Radiology 2013;266:38-61. [PMID: 23264526 DOI: 10.1148/radiol.12112512] [Cited by in Crossref: 95] [Cited by in F6Publishing: 68] [Article Influence: 11.9] [Reference Citation Analysis]
4 Tharian B, Tsiopoulos F, George N, Pietro SD, Attili F, Larghi A. Endoscopic ultrasound fine needle aspiration: Technique and applications in clinical practice. World J Gastrointest Endosc 2012; 4(12): 532-544 [PMID: 23293723 DOI: 10.4253/wjge.v4.i12.532] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
5 Kurita Y, Hara K, Kuwahara T, Mizuno N, Okuno N, Haba S, Okuno M, Natsume S, Senda Y, Kubota K, Nakajima A, Niwa Y, Shimizu Y. Comparison of prognosis between observation and surgical resection groups with small sporadic non-functional pancreatic neuroendocrine neoplasms without distant metastasis. J Gastroenterol 2020;55:543-52. [PMID: 31858231 DOI: 10.1007/s00535-019-01655-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
6 Leeds JS, Nayar MK, Bekkali NLH, Wilson CH, Johnson SJ, Haugk B, Darne A, Oppong KW. Endoscopic ultrasound-guided fine-needle biopsy is superior to fine-needle aspiration in assessing pancreatic neuroendocrine tumors. Endosc Int Open 2019;7:E1281-7. [PMID: 31579710 DOI: 10.1055/a-0990-9611] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Kawamoto S, Johnson PT, Shi C, Singhi AD, Hruban RH, Wolfgang CL, Edil BH, Fishman EK. Pancreatic neuroendocrine tumor with cystlike changes: evaluation with MDCT. AJR Am J Roentgenol. 2013;200:W283-W290. [PMID: 23436873 DOI: 10.2214/ajr.12.8941] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
8 Gaujoux S, Sauvanet A, Belghiti J. Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors. Target Oncol 2012;7:153-9. [PMID: 22923166 DOI: 10.1007/s11523-012-0230-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
9 黄颖秋. 胰腺内分泌肿瘤的研究进展. 世界华人消化杂志 2011; 19(15): 1541-1549 [DOI: 10.11569/wcjd.v19.i15.1541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Usui M, Kuriyama N, Uchida K, Kishiwada M, Mizuno S, Sakurai H, Tabata M, Shiraishi T, Isaji S. Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg 2014;7:271-4. [PMID: 25131327 DOI: 10.1111/ases.12107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Lee NJ, Hruban RH, Fishman EK. Pancreatic neuroendocrine tumor: review of heterogeneous spectrum of CT appearance. Abdom Radiol 2018;43:3025-34. [DOI: 10.1007/s00261-018-1574-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
12 Kaosombatwattana U, Hirooka Y, Kawashima H, Ohno E, Ishikawa T, Suhara H, Goto H. Neuroendocrine neoplasm of pancreas with cystic degeneration mimicking mucinous cystic neoplasm. Clin J Gastroenterol 2018;11:333-7. [PMID: 29536430 DOI: 10.1007/s12328-018-0846-4] [Reference Citation Analysis]
13 Tatsumoto S, Kodama Y, Sakurai Y, Shinohara T, Katanuma A, Maguchi H. Pancreatic neuroendocrine neoplasm: correlation between computed tomography enhancement patterns and prognostic factors of surgical and endoscopic ultrasound-guided fine-needle aspiration biopsy specimens. Abdom Imaging 2013;38:358-66. [DOI: 10.1007/s00261-012-9953-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
14 Okumura Y, Noda T, Eguchi H, Iwagami Y, Yamada D, Asaoka T, Kawamoto K, Gotoh K, Kobayashi S, Umeshita K, Hashimoto Y, Takeda Y, Tanemura M, Shigekawa M, Morii E, Takehara T, Mori M, Doki Y. Middle segment pancreatectomy for a solid serous cystadenoma diagnosed by MRCP and review of the literature: A case report. Mol Clin Oncol 2018;8:675-82. [PMID: 29725534 DOI: 10.3892/mco.2018.1598] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Carlinfante G, Baccarini P, Berretti D, Cassetti T, Cavina M, Conigliaro R, De Pellegrin A, Di Tommaso L, Fabbri C, Fornelli A, Frasoldati A, Gardini G, Losi L, Maccio L, Manta R, Pagano N, Sassatelli R, Serra S, Camellini L. Ki-67 cytological index can distinguish well-differentiated from poorly differentiated pancreatic neuroendocrine tumors: a comparative cytohistological study of 53 cases. Virchows Arch. 2014;465:49-55. [PMID: 24807732 DOI: 10.1007/s00428-014-1585-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
16 Nakano A, Hayano K, Tochigi T, Mashiko T, Masuoka Y, Yamamoto S, Ozawa S, Nakagohri T. Prediction of non-functioning pancreatic neuroendocrine tumor grades with fractal analysis of preoperative contrast-enhanced computed tomography images. Eur J Radiol 2021;141:109803. [PMID: 34090111 DOI: 10.1016/j.ejrad.2021.109803] [Reference Citation Analysis]
17 Raoof M, Jutric Z, Melstrom LG, Lee B, Li D, Warner SG, Fong Y, Singh G. Prognostic significance of Chromogranin A in small pancreatic neuroendocrine tumors. Surgery 2019;165:760-6. [PMID: 30447803 DOI: 10.1016/j.surg.2018.10.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
18 Bernstein J, Ustun B, Alomari A, Bao F, Aslanian HR, Siddiqui U, Chhieng D, Cai G. Performance of endoscopic ultrasound-guided fine needle aspiration in diagnosing pancreatic neuroendocrine tumors. Cytojournal 2013;10:10. [PMID: 23858320 DOI: 10.4103/1742-6413.112648] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
19 Yang D, Wang D, Qiu Y, Tian X, Zuo D, Dong Y, Lou W, Wang W. Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis. Clin Hemorheol Microcirc 2021. [PMID: 34602462 DOI: 10.3233/CH-211269] [Reference Citation Analysis]
20 Moore MD, Finnerty B, Gray KD, Hoda R, Liu YF, Soong L, Beninato T, Rao R, Zarnegar R, Fahey TJ 3rd. Decreased UCHL1 expression as a cytologic biomarker for aggressive behavior in pancreatic neuroendocrine tumors. Surgery 2018;163:226-31. [PMID: 29150024 DOI: 10.1016/j.surg.2017.04.040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Tomimaru Y, Eguchi H, Tatsumi M, Kim T, Hama N, Wada H, Kawamoto K, Kobayashi S, Morii E, Mori M, Doki Y, Nagano H. Clinical utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors. Surgery 2015;157:269-76. [DOI: 10.1016/j.surg.2014.09.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
22 Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review. Diagnostics (Basel) 2015;5:119-76. [PMID: 26854147 DOI: 10.3390/diagnostics5020119] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 8.3] [Reference Citation Analysis]
23 Melita G, Pallio S, Tortora A, Crinò SF, Macrì A, Dionigi G. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:2638. [PMID: 34203922 DOI: 10.3390/jcm10122638] [Reference Citation Analysis]
24 Sagami R, Nishikiori H, Ikuyama S, Murakami K. Rupture of small cystic pancreatic neuroendocrine tumor with many microtumors. World J Gastroenterol 2017; 23(37): 6911-6919 [PMID: 29085235 DOI: 10.3748/wjg.v23.i37.6911] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Gaujoux S, Gonen M, Tang L, Klimstra D, Brennan MF, D’angelica M, Dematteo R, Allen PJ, Jarnagin W, Fong Y. Synchronous Resection of Primary and Liver Metastases for Neuroendocrine Tumors. Ann Surg Oncol 2012;19:4270-7. [DOI: 10.1245/s10434-012-2462-8] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
26 Cherif R, Gaujoux S, Couvelard A, Dokmak S, Vuillerme MP, Ruszniewski P, Belghiti J, Sauvanet A. Parenchyma-sparing resections for pancreatic neuroendocrine tumors. J Gastrointest Surg. 2012;16:2045-2055. [PMID: 22911124 DOI: 10.1007/s11605-012-2002-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 7.7] [Reference Citation Analysis]
27 Téllez-Ávila FI, Duarte-Medrano G, Herrera-Mora D, Lopez-Arce G, Leal-García M, Ramírez-Martínez M, Ramírez-Luna M. Endoscopic Ultrasound in Pediatric Patients With Pancreatobiliary Disease. Surg Laparosc Endosc Percutan Tech 2019;29:271-4. [PMID: 31259867 DOI: 10.1097/SLE.0000000000000673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
28 Iglesias-Garcia J, Lariño-Noia J, Domínguez-Muñoz JE. When to puncture, when not to puncture: Pancreatic masses. Endosc Ultrasound 2014;3:91-7. [PMID: 24955338 DOI: 10.4103/2303-9027.123007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
29 Larghi A, Capurso G, Carnuccio A, Ricci R, Alfieri S, Galasso D, Lugli F, Bianchi A, Panzuto F, De Marinis L. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc. 2012;76:570-577. [PMID: 22898415 DOI: 10.1016/j.gie.2012.04.477] [Cited by in Crossref: 106] [Cited by in F6Publishing: 102] [Article Influence: 13.3] [Reference Citation Analysis]
30 Ito T, Hijioka S, Masui T, Kasajima A, Nakamoto Y, Kobayashi N, Komoto I, Hijioka M, Lee L, Igarashi H, Jensen RT, Imamura M. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan. J Gastroenterol 2017;52:9-18. [PMID: 27539256 DOI: 10.1007/s00535-016-1250-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
31 Collins JA, Ali SZ, Vandenbussche CJ. Pancreatic Cytopathology. Surgical Pathology Clinics 2016;9:661-76. [DOI: 10.1016/j.path.2016.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
32 Matsubayashi H, Matsui T, Yabuuchi Y, Imai K, Tanaka M, Kakushima N, Sasaki K, Ono H. Endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of solid pancreaticobiliary lesions: Clinical aspects to improve the diagnosis. World J Gastroenterol 2016; 22(2): 628-640 [PMID: 26811612 DOI: 10.3748/wjg.v22.i2.628] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
33 Vinayek R, Capurso G, Larghi A. Grading of EUS-FNA cytologic specimens from patients with pancreatic neuroendocrine neoplasms: it is time move to tissue core biopsy? Gland Surg. 2014;3:222-225. [PMID: 25493252 DOI: 10.3978/j.issn.2227-684x.2014.07.03] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
34 Tejedor Bravo M, Justo LMA, Lasala JP, Moreira Vicente VF, Ruiz AC, Scapa MDLÁM. Acute Pancreatitis Secondary to Neuroendocrine Pancreatic Tumors: Report of 3 Cases and Literature Review. Pancreas 2012;41:485-9. [DOI: 10.1097/mpa.0b013e318227adef] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
35 Iwasaki M, Tsuchida K, Jinnai H, Komatsubara T, Arisaka T, Tsunemi M, Nakano M, Iijima M, Hiraishi H. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases. Intern Med. 2017;56:517-522. [PMID: 28250297 DOI: 10.2169/internalmedicine.56.7512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wangermez M. Endoscopic ultrasound of pancreatic tumors.Diagn Interv Imaging. 2016;97:1287-1295. [PMID: 27866871 DOI: 10.1016/j.diii.2016.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
38 Unno J, Kanno A, Masamune A, Kasajima A, Fujishima F, Ishida K, Hamada S, Kume K, Kikuta K, Hirota M. The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification. Scand J Gastroenterol. 2014;49:1367-1374. [PMID: 25180490 DOI: 10.3109/00365521.2014.934909] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
39 Atiq M, Bhutani MS, Bektas M, Lee JE, Gong Y, Tamm EP, Shah CP, Ross WA, Yao J, Raju GS. EUS-FNA for pancreatic neuroendocrine tumors: a tertiary cancer center experience. Dig Dis Sci. 2012;57:791-800. [PMID: 21964743 DOI: 10.1007/s10620-011-1912-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
40 Tanaka H, Matsusaki S, Baba Y, Isono Y, Kumazawa H, Sase T, Okano H, Saito T, Mukai K, Kaneko H. Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate. Clin J Gastroenterol. 2015;8:414-420. [PMID: 26439620 DOI: 10.1007/s12328-015-0609-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
41 Tacelli M, Petrone MC, Capurso G, Muffatti F, Andreasi V, Partelli S, Doglioni C, Falconi M, Arcidiacono PG. Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification. Endosc Ultrasound 2021;10:372-80. [PMID: 34677159 DOI: 10.4103/EUS-D-20-00261] [Reference Citation Analysis]
42 Toshima F, Inoue D, Komori T, Yoshida K, Yoneda N, Minami T, Matsui O, Ikeda H, Gabata T. Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors? Jpn J Radiol 2017;35:242-53. [PMID: 28258323 DOI: 10.1007/s11604-017-0627-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Attili F, Capurso G, Vanella G, Fuccio L, Fave GD, Costamagna G, Larghi A. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms. Digestive and Liver Disease 2014;46:9-17. [DOI: 10.1016/j.dld.2013.04.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
44 Sinclair TJ, Poultsides GA. Islet Tumors: Resect or Follow? Adv Surg 2020;54:69-88. [PMID: 32713440 DOI: 10.1016/j.yasu.2020.04.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Kimura W, Tezuka K, Hirai I. Surgical management of pancreatic neuroendocrine tumors. Surg Today. 2011;41:1332-1343. [PMID: 21922354 DOI: 10.1007/s00595-011-4547-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
46 Weynand B, Borbath I, Bernard V, Sempoux C, Gigot JF, Hubert C, Lannoy V, Deprez PH, Jouret-Mourin A. Pancreatic neuroendocrine tumour grading on endoscopic ultrasound-guided fine needle aspiration: high reproducibility and inter-observer agreement of the Ki-67 labelling index. Cytopathology. 2014;25:389-395. [PMID: 24750272 DOI: 10.1111/cyt.12111] [Cited by in Crossref: 22] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
47 Becker-Weidman D, Floré B, Mortelé KJ. Xanthogranulomatous pancreatitis: A review of the imaging characteristics of this rare and often misdiagnosed lesion of the pancreas. Clin Imaging 2017;45:12-7. [PMID: 28554050 DOI: 10.1016/j.clinimag.2017.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Shrikhande SV, Sirohi B, Goel M, Barreto SG. Pancreatic neuroendocrine tumors. Indian J Gastroenterol 2013;32:3-17. [PMID: 23054950 DOI: 10.1007/s12664-012-0257-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
49 Halvorson SA, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M, Martin M, Sheppard B. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. J Gen Intern Med. 2013;28:1525-1529. [PMID: 23681843 DOI: 10.1007/s11606-013-2490-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
50 Eusebi LH, Thorburn D, Toumpanakis C, Frazzoni L, Johnson G, Vessal S, Luong TV, Caplin M, Pereira SP. Endoscopic ultrasound-guided fine-needle aspiration vs fine-needle biopsy for the diagnosis of pancreatic neuroendocrine tumors. Endosc Int Open 2019;7:E1393-9. [PMID: 31673610 DOI: 10.1055/a-0967-4684] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
51 Holzer K. [Surgical strategies for small sporadic neuroendocrine pancreatic tumors]. Chirurg 2018;89:422-7. [PMID: 29637243 DOI: 10.1007/s00104-018-0632-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rebours V, Cordova J, Couvelard A, Fabre M, Palazzo L, Vullierme MP, Hentic O, Sauvanet A, Aubert A, Bedossa P. Can pancreatic neuroendocrine tumour biopsy accurately determine pathological characteristics? Dig Liver Dis. 2015;47:973-977. [PMID: 26169284 DOI: 10.1016/j.dld.2015.06.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]